Biogen Corp (BIIB) - Proyeksi bathi mangsa ngarep
Biogen Inc. (BIIB) specializes in developing advanced therapies for brain diseases. This price chart reflects the impact of high operating leverage, where colossal R&D costs for SMA can shift to superprofits upon success. The current metric stands at 2.40. The company is currently intensively preparing new dementia products for launch, although global political fragmentation complicates the cross-border transportation of biomaterials.
Rincian metrik lan analitis perusahaan Biogen Inc (BIIB)
- rega saham lan konsensus proyeksi valuasi:
- indikator kapitalisasi pasar:
- indikator kapitalisasi buku:
- data utang lan likuiditas:
Total Utang marang Modal Biogen Inc.|BIIB - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Biogen Corp|BIIB - Utang agregat perusahaan|Utang marang nilai buku Biogen|BIIB - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Biogen|Likuiditas cepet biogen.com
- data bathi resik lan rasio valuasi:
BIIB - Bathi perusahaan|Proyeksi bathi mangsa ngarep Biogen Inc.|BIIB - Koefisien rega marang bathi|Prakiraan rega marang bathi Biogen|BIIB - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Biogen|BIIB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Biogen|BIIB - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan biogen.com|BIIB - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Biogen Inc.
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:Biogen Inc.
For Biogen Inc. (BIIB), the launch of innovative CNS drugs and cost optimization are intended to offset declining revenues from legacy product lines. An analysis of projected revenue and profit allows for an assessment of the business trajectory via daily price action, where growth in these metrics confirms the strategy's effectiveness, while historical highs signal correction risks for this investment asset.
Analisis pesaing Biogen Inc.
NBIX (Neurocrine Biosciences) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake RGC|Proyeksi bathi mangsa ngarep AXSM|Prakiraan bathi perusahaan ACADIA Pharma|Bathi sing dikarepake Xenon Pharmaceuticals Inc XENE|Viking Therapeutics Corp (VKTX) - Bathi resik sing dikarepake|Supernus Pharmaceuticals - Proyeksi bathi mangsa ngarep|Proyeksi bathi resik catalystpharma.com (CPRX)|DNLI: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Harmony Biosciences Inc (HRMY)|Bathi sing dikarepake Biohaven Pharmaceutical|Prakiraan bathi resik AMLX (Amylyx Corp)|Bathi mangsa ngarep TRVI (Trevi Therapeutics)|PRAX (praxismedicines.com) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep AVXL (Anavex Life Sciences Corp.)|Prakiraan bathi perusahaan CeriBell Inc (CBLL)|PRTA - Bathi sing dikarepake|ALEC (Alector, Inc.) - Prakiraan bathi resik|ANNX: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Omeros|Bathi mangsa ngarep NGNE|AC Immune S.A. (ACIU) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep VYGR|Bathi sing dikarepake NMRA (Neumora Corp)|Proyeksi bathi mangsa ngarep SCLX (Scilex Holding Company)|Prakiraan bathi perusahaan tevogen.com (TVGN)|Alpha Cognition Corp - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan cogrx.com CGTX|IKT: Proyeksi bathi mangsa ngarep|SAVA (Cassava Pharma) - Bathi sing dikarepake|Bathi sing dikarepake Assertio Holdings|Prakiraan bathi resik COYA (Coya)|Proyeksi bathi mangsa ngarep VTGN|OVID - Bathi resik sing dikarepake|Acumen Pharma - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep CervoMed Corporation CRVO|ATHE - Bathi sing dikarepake|Penghasilan resik sing dikarepake CLNN (Clene Inc.)|pepgen.com (PEPG) - Bathi sing dikarepake|Bathi resik sing dikarepake jupiterneurosciences.com (JUNS)|RLMD (Relmada) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake ANVS|Proyeksi bathi mangsa ngarep GRCE|Prakiraan bathi perusahaan fireflyneuro.com|Bathi sing dikarepake Klotho Neurosciences KLTO|NeuroSense Therapeutics Ltd (NRSN) - Bathi resik sing dikarepake|Reviva Pharmaceuticals Holdings - Proyeksi bathi mangsa ngarep|Proyeksi bathi resik MetaVia Inc (MTVA)|NRXS: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Helius Medical Technologies (HSDT)|Bathi sing dikarepake Passage Bio Inc.|Prakiraan bathi resik NEUP (Neuphoria)|Bathi mangsa ngarep NERV (Minerva Neurosciences Corp)|ATHA (Athira Pharma Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep ADXN (Addex Therapeutics)|Prakiraan bathi perusahaan Alzamend Neuro Inc. (ALZN)|CYCN - Bathi sing dikarepake|PTIX (Protagenic Therapeutics) - Prakiraan bathi resik|KTTA: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Cortigent|Bathi mangsa ngarep ATXI|brainstorm-cell.com (BCLI) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep CARA|Bathi sing dikarepake CHRO (Chromocell Therapeutics Corp)|Proyeksi bathi mangsa ngarep ELYM (Eliem Therapeutics Inc.)|Prakiraan bathi perusahaan Intra-Cellular Therapies Inc. (ITCI)|Longboard Pharmaceuticals - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan marinuspharma.com MRNS|NKGN: Proyeksi bathi mangsa ngarep|NRBO (NeuroBo Pharmaceuticals Inc) - Bathi sing dikarepake|Bathi sing dikarepake Sage Therapeutics, Inc|Prakiraan bathi resik SNPX (Synaptogenix, Inc)|Proyeksi bathi mangsa ngarep TRVN|VIGL - Bathi resik sing dikarepake|Anew Medical, Inc. - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Cerevel Therapeutics Inc CERE
